Search Results - Martin F. Bachmann

Refine Results
  1. 1

    On the complexity of IgE: The role of structural flexibility and glycosylation for binding its receptors by Kevin Plattner, Kevin Plattner, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann, Monique Vogel, Monique Vogel

    Published in Frontiers in Allergy (2023-03-01)
    Get full text
    Article


  2. 2

    The 5th virus-like particle and nano-particle vaccines (VLPNPV) conference by Paul Engeroff, Martin F. Bachmann

    Published in Expert Review of Vaccines (2019-01-01)
    Get full text
    Article


  3. 3

    Special Issue “Virus-Like Particle Vaccines” by Monique Vogel, Martin F. Bachmann

    Published in Viruses (2020-08-01)
    Get full text
    Article


  4. 4

    On the role of allergen-specific IgG subclasses for blocking human basophil activation by Simon Zinkhan, Simon Zinkhan, Franziska Thoms, Gilles Augusto, Gilles Augusto, Gilles Augusto, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann

    Published in Frontiers in Immunology (2022-10-01)
    Get full text
    Article


  5. 5

    COVID-19: Mechanisms of Vaccination and Immunity by Daniel E. Speiser, Martin F. Bachmann

    Published in Vaccines (2020-07-01)
    Get full text
    Article


  6. 6

    IgG in the control of FcεRI activation: a battle on multiple fronts by Federico Storni, Federico Storni, Monique Vogel, Monique Vogel, Martin F. Bachmann, Martin F. Bachmann, Paul Engeroff, Paul Engeroff

    Published in Frontiers in Immunology (2024-01-01)
    Get full text
    Article


  7. 7

    Successful Allergen-Specific Immunotherapy: Induction of Unresponsiveness by ‘Vaccination’ by Martin F. Bachmann, Monique Vogel, Daniel E. Speiser

    Published in Vaccines (2023-12-01)
    Get full text
    Article


  8. 8

    Hybrid Sindbis/Epstein-Barr virus episomal expression vector for inducible production of proteins by Lidia Ivanova, Johanna Brändli, Philippe Saudan, Martin F. Bachmann

    Published in BioTechniques (2005-08-01)
    Get full text
    Article


  9. 9

    Increased receptor affinity of SARS-CoV-2: a new immune escape mechanism by Martin F. Bachmann, Mona O. Mohsen, Daniel E. Speiser

    Published in npj Vaccines (2022-05-01)
    Get full text
    Article


  10. 10

    Type of RNA Packed in VLPs Impacts IgG Class Switching—Implications for an Influenza Vaccine Design by Ariane C. Gomes, E. S. Roesti, Aadil El-Turabi, Martin F. Bachmann

    Published in Vaccines (2019-06-01)
    Get full text
    Article


  11. 11

    Virus-like particles: a versatile and effective vaccine platform by Martin F. Bachmann, Pierre van Damme, Florian Lienert, Tino F. Schwarz

    Published in Expert Review of Vaccines (2025-12-01)
    Get full text
    Article


  12. 12

    Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies by Anne-Cathrine S. Vogt, Anne-Cathrine S. Vogt, Lukas Jörg, Lukas Jörg, Byron Martina, Byron Martina, Pascal S. Krenger, Pascal S. Krenger, Xinyue Chang, Xinyue Chang, Andris Zeltins, Monique Vogel, Monique Vogel, Mona O. Mohsen, Mona O. Mohsen, Martin F. Bachmann, Martin F. Bachmann, Martin F. Bachmann

    Published in Frontiers in Immunology (2022-06-01)
    Get full text
    Article


  13. 13

    SARS-CoV-2 structural features may explain limited neutralizing-antibody responses by Martin F. Bachmann, Mona O. Mohsen, Lisha Zha, Monique Vogel, Daniel E. Speiser

    Published in npj Vaccines (2021-01-01)
    Get full text
    Article


  14. 14

    Anti-IL-6 Receptor Treatment in Giant Cell Arteritis Patients Reduces Levels of IL-1β-Receptor Antagonist but Not IL-1β by Joana J. da Costa, Lisa Christ, Peter M. Villiger, Monique Vogel, Martin F. Bachmann

    Published in Rheumato (2024-03-01)
    Get full text
    Article


  15. 15

    Comparison of Bacterial Expression Systems Based on Potato Virus Y-like Particles for Vaccine Generation by Anete Ogrina, Dace Skrastina, Ina Balke, Ieva Kalnciema, Juris Jansons, Martin F. Bachmann, Andris Zeltins

    Published in Vaccines (2022-03-01)
    Get full text
    Article


  16. 16

    Anti-IAPP Monoclonal Antibody Improves Clinical Symptoms in a Mouse Model of Type 2 Diabetes by Anne-Cathrine S. Vogt, Elisa S. Roesti, Mona O. Mohsen, Ainars Leonchiks, Monique Vogel, Martin F. Bachmann

    Published in Vaccines (2021-11-01)
    Get full text
    Article


  17. 17

    Bacterial expression systems based on Tymovirus-like particles for the presentation of vaccine antigens by Anete Ogrina, Ina Balke, Ieva Kalnciema, Dace Skrastina, Juris Jansons, Martin F. Bachmann, Andris Zeltins

    Published in Frontiers in Microbiology (2023-03-01)
    Get full text
    Article


  18. 18

    Induction of Broadly Cross-Reactive Antibodies by Displaying Receptor Binding Domains of SARS-CoV-2 on Virus-like Particles by Xinyue Chang, Xuelan Liu, Mona O. Mohsen, Andris Zeltins, Byron Martina, Monique Vogel, Martin F. Bachmann

    Published in Vaccines (2022-02-01)
    Get full text
    Article


  19. 19

    Rapid functional cloning of cell adhesion molecules by Christiane Ruedl, Monika Bauer, Roger R. Beerli, Ute Lässing, Klaus Dietmeier, Lidia Ivanova, Lorenz Vogt, Philippe Saudan, Martin F. Bachmann

    Published in BioTechniques (2004-12-01)
    Get full text
    Article


  20. 20

    A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain by Xinyue Chang, Andris Zeltins, Mona O. Mohsen, Zahra Gharailoo, Lisha Zha, Xuelan Liu, Senta Walton, Monique Vogel, Martin F. Bachmann

    Published in Vaccines (2021-11-01)
    Get full text
    Article


Search Tools: